Pilot Study of an Advance Care Planning Intervention Among Persons With Dementia

Sponsor
Oregon Health and Science University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05049291
Collaborator
University of Pennsylvania (Other)
175
1
2
5.5
32.1

Study Details

Study Description

Brief Summary

Advance care planning allows people to have their wishes taken into account even in the advanced stages of the persons' condition and at the end of life when the person may be unable to communicate. However, a recent review found an absence of high-quality guidelines for advanced care planning in dementia care. Since few evidence-based resources exist, the investigators propose a study to generate, refine, and pilot test an education information sheet designed to promote advanced care planning among families of persons with dementia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: telehealth advance care planning
N/A

Detailed Description

To determine the feasibility, acceptability and preliminary efficacy of an education information sheet to promote advance care planning among family members of persons with advanced dementia in long-term services and support facilities.

Introducing an education information sheet containing prognosis and outcomes will be feasible, acceptable, and increase self-efficacy and do-not-hospitalize decision preferences among family members of persons with advanced dementia.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
175 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Pilot Study of an Advance Care Planning Intervention Among Persons With Dementia in Long-term Services and Support Facilities
Anticipated Study Start Date :
Jul 18, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

One time receipt and review of an information sheet

Behavioral: telehealth advance care planning
An education information sheet containing prognosis and outcomes of acute care and intensive treatments

No Intervention: Non-Intervention

Usual care will be delivered per standards of care.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of Information Sheet among Study Population [6 months]

    Feasibility of the information sheet is defined as the consent rate of family members who are offered enrollment. This will be calculatd as a percent of family members (number of enrolled participants/number of eligible participants offered enrollment)

  2. Acceptibility of Decision Aid Tool [6 months]

    Acceptability using an adapted tool (https://decisionaid.ohri.ca/eval_accept.html) which measures the ratings of comprehensibility of the information sheet among participants in the intervention group. Responses are reported descriptively in terms of proportions responding positively or negatively on each criteria.

Secondary Outcome Measures

  1. Decision Self-efficacy Scale [6 months]

    Measures self-confidence or belief in one's abilities in decision making, including shared decision making. Eleven responses are measured on a 0-4 likert scale and a final summed scale is converted to a 0-100 range (scores are summed, divided by 11, then multiplied by 25). A score of zero means low self efficacy and score of 100 means extremely high self efficacy.

  2. Family Member Decision-Making Self-Efficacy Scale [6 months]

    Measures family member self-efficacy in medical decision-making on behalf of a loved one. This scale has two versions, one for conscious and one for unconscious loved ones, which we will use accordingly. Thirteen items are measured on a 0-5 Likert scale with 1 being "cannot do at all" and 5 being "certain I can do." Higher scores indicate higher decision making self-efficacy.

  3. Adaptation of Advance Care Planning Engagement Survey [6 months]

    Questions adapted from an 82-item questionnaire that measures advance care planning engagement in terms of knowledge, contemplation, self-efficacy and readiness. We include 10 questions from the measure. We used a mean imputation approach. All available data were included to create an average 5-point Likert score.

  4. Preparation for Decision-Making Scale [6 months]

    Measures perception of the usefulness of a decision support tool in preparing respondent for decision-making. Responses are on a Likert scale of 1-5 with one being "not at all" and five being " a great deal." Items are summed for scoring. A higher score indicates a higher level of perceived helpfulness in preparing for decision-making.

  5. Adaptation of Advance Care Planning Engagement for Surrogates Survey [6 months]

    We adapted 9 items from the 17-item Advance Care Planning for Surrogates survey. Response options are on a 5-point Likert scale. We will calculate a summary score, with higher scores indicates a higher level of engagement.

  6. Knowledge about Dementia [6 months]

    Six questions to assess family members' knowledge about dementia were developed for this pilot study. All questions are true/false. Each correct answer will be coded as 1, each incorrect answer will be scored as 0. Higher scores indicate more knowledge.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Family member of a person with a diagnosis of dementia (any type)

  • English-speaking family member

  • Family member of a person with dementia admitted to a nursing home

Exclusion Criteria:
  • Inability to understand/read English

  • Advance directive already in patient chart

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Oregon Health and Science University
  • University of Pennsylvania

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Donald Sullivan, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT05049291
Other Study ID Numbers:
  • STUDY00021951
First Posted:
Sep 20, 2021
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022